Big Move For Enzo Biochem, Inc.
Fri, Mar 17, 2023 at 07:12 PM
Enzo Biochem, Inc. (ENZ:NYSE) soared at $2.25, a gain of 89.1%. On Fri, Mar 17, 2023, ENZ:NYSE hit a New 2-Week High of $2.25. The stock got featured on our News Catalysts scanner on Thu, Mar 16, 2023 at 04:46 PM in the 'BIOTECH' category. From Fri, Mar 03, 2023, the stock recorded 40.00% Up Days and 36.36% Green Days
About Enzo Biochem, Inc. (ENZ:NYSE)
Enzo Biochem Inc is engaged in research, development, manufacturing and marketing of health care products, platforms and services. The Company's business segments are Enzo Clinical Labs, Enzo Life Sciences, and Enzo Therapeutics.
Top 10 Gainers:
- Local Bounti Corporation (LOCL:NYSE), 110.65%
- Enzo Biochem, Inc. (ENZ:NYSE), 89.08%
- Wejo Group Limited (WEJO:NASDAQ), 76.3%
- Science 37 Holdings Inc. (SNCE:NASDAQ), 58.1%
- Histogen Inc. (HSTO:NASDAQ), 53%
- a.k.a. Brands Holding Corp. (AKA:NYSE), 46.67%
- Bakkt Holdings Inc. Class A (BKKT:NYSE), 44.54%
- IronNet Inc. (IRNT:NYSE), 44.25%
- Home Point Capital Inc. (HMPT:NASDAQ), 40.88%
- Baosheng Media Group Holdings Limited (BAOS:NASDAQ), 40.18%